
    
      To evaluate the therapeutic efficacy and safety of DSXS topical product (Taro
      Pharmaceuticals, U.S.A., Inc.) compared to a Vehicle topical product (Taro Pharmaceuticals,
      U.S.A., Inc.) in patients with mild to severe scalp psoriasis.
    
  